203 related articles for article (PubMed ID: 38696074)
1. Cholesterol and Immune Microenvironment: Path Towards Tumorigenesis.
Saad EE; Michel R; Borahay MA
Curr Nutr Rep; 2024 May; ():. PubMed ID: 38696074
[TBL] [Abstract][Full Text] [Related]
2. Benzo[a]pyrene immunogenetics and immune archetype reprogramming of lung.
Abd El-Fattah EE; Abdelhamid AM
Toxicology; 2021 Nov; 463():152994. PubMed ID: 34678320
[TBL] [Abstract][Full Text] [Related]
3. Metformin modulate immune fitness in hepatocellular carcinoma: Molecular and cellular approach.
Abd El-Fattah EE; Zakaria AY
Int Immunopharmacol; 2022 Aug; 109():108889. PubMed ID: 35679661
[TBL] [Abstract][Full Text] [Related]
4. T-cell programming in pancreatic adenocarcinoma: a review.
Seo YD; Pillarisetty VG
Cancer Gene Ther; 2017 Mar; 24(3):106-113. PubMed ID: 27910859
[TBL] [Abstract][Full Text] [Related]
5. Methionine enkephalin (MENK) inhibits tumor growth through regulating CD4+Foxp3+ regulatory T cells (Tregs) in mice.
Li X; Meng Y; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
Cancer Biol Ther; 2015; 16(3):450-9. PubMed ID: 25701137
[TBL] [Abstract][Full Text] [Related]
6. Emerging role of natural products in cancer immunotherapy.
Dong S; Guo X; Han F; He Z; Wang Y
Acta Pharm Sin B; 2022 Mar; 12(3):1163-1185. PubMed ID: 35530162
[TBL] [Abstract][Full Text] [Related]
7. Qntrolling the LncRNA HULC-Tregs-PD-1 axis inhibits immune escape in the tumor microenvironment.
Wang X; Mo X; Yang Z; Zhao C
Heliyon; 2024 Apr; 10(7):e28386. PubMed ID: 38560250
[TBL] [Abstract][Full Text] [Related]
8. Promoted Generation of T Helper 1-Like Regulatory T Cells After Transient Middle Cerebral Artery Occlusion in Type-2 Diabetic Mice.
Jian L; Hu Y; Gao M; Shu L
Immunol Invest; 2023 Nov; 52(4):482-498. PubMed ID: 37076315
[TBL] [Abstract][Full Text] [Related]
9. IL-33 in the tumor microenvironment is associated with the accumulation of FoxP3-positive regulatory T cells in human esophageal carcinomas.
Cui G; Li Z; Ren J; Yuan A
Virchows Arch; 2019 Nov; 475(5):579-586. PubMed ID: 31062086
[TBL] [Abstract][Full Text] [Related]
10. Role of LAP
Zhong W; Jiang ZY; Zhang L; Huang JH; Wang SJ; Liao C; Cai B; Chen LS; Zhang S; Guo Y; Cao YF; Gao F
World J Gastroenterol; 2017 Jan; 23(3):455-463. PubMed ID: 28210081
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-23 receptor defines T helper 1-like regulatory T cells in oral squamous cell carcinoma.
Li W; An N; Wang M; Liu X; Mei Z
Immun Inflamm Dis; 2022 Dec; 10(12):e746. PubMed ID: 36444617
[TBL] [Abstract][Full Text] [Related]
12. Contribution of regulatory T cells to cancer: A review.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):7983-7993. PubMed ID: 30317612
[TBL] [Abstract][Full Text] [Related]
13. Differential potency of regulatory T cell-mediated immunosuppression in kidney tumors compared to subcutaneous tumors.
Devaud C; Westwood JA; Teng MW; John LB; Yong CS; Duong CP; Smyth MJ; Darcy PK; Kershaw MH
Oncoimmunology; 2014 Nov; 3(11):e963395. PubMed ID: 25941590
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive tumor microenvironment and uterine fibroids: Role in collagen synthesis.
Saad EE; Michel R; Borahay MA
Cytokine Growth Factor Rev; 2024 Feb; 75():93-100. PubMed ID: 37839993
[TBL] [Abstract][Full Text] [Related]
15. CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer.
Pu N; Zhao G; Yin H; Li JA; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W
J Transl Med; 2018 Oct; 16(1):294. PubMed ID: 30359281
[TBL] [Abstract][Full Text] [Related]
16. CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma.
Guo XJ; Lu JC; Zeng HY; Zhou R; Sun QM; Yang GH; Pei YZ; Meng XL; Shen YH; Zhang PF; Cai JB; Huang PX; Ke AW; Shi YH; Zhou J; Fan J; Chen Y; Yang LX; Shi GM; Huang XY
Front Immunol; 2021; 12():705378. PubMed ID: 34526987
[TBL] [Abstract][Full Text] [Related]
17. Targeting CD166
El-Ashmawy NE; Salem ML; Abd El-Fattah EE; Khedr EG
Toxicol Appl Pharmacol; 2021 Oct; 429():115699. PubMed ID: 34437932
[TBL] [Abstract][Full Text] [Related]
18. Immune Checkpoints in Circulating and Tumor-Infiltrating CD4
Toor SM; Murshed K; Al-Dhaheri M; Khawar M; Abu Nada M; Elkord E
Front Immunol; 2019; 10():2936. PubMed ID: 31921188
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
20. The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma.
Monjaras-Avila CU; Lorenzo-Leal AC; Luque-Badillo AC; D'Costa N; Chavez-Muñoz C; Bach H
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]